BioGaia AB (LTS:0GTN) Short Percentage of Float

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LTS:0GTN BioGaia AB LTS:0GTN
95 GF Score
Price kr115.51
GF Value kr127.39
Valuation Fairly Valued
! 2 Warning Signs
View Full Analysis

What is BioGaia AB Short Percentage of Float?

Short Percentage of Float is the percentage of shares shorted compared to the float.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

LTS:0GTN vs ZTS, UTHR: Short Percentage of Float Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, BioGaia AB's Short Percentage of Float, along with its competitors' market caps and Short Percentage of Float data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BioGaia AB Short Percentage of Float vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, BioGaia AB's Short Percentage of Float distribution charts can be found below:

* The bar in red indicates where BioGaia AB's Short Percentage of Float falls into.


LTS:0GTN
95GF Score
BioGaia AB LTS:0GTN
Short Percentage of Float is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is BioGaia AB (LTS:0GTN) Overvalued in 2026?

Based on GuruFocus' analysis, BioGaia AB stock appears to be undervalued. The current stock price of kr115.51 is trading 9.3% below its estimated GF Value™ of kr127.39. GuruFocus considers BioGaia AB to be Fairly Valued.

Key valuation signals for LTS:0GTN:

  • Short Percentage of Float:
  • GF Value™: kr127.39 vs. price of kr115.51 (9.3% below fair value)
  • GF Score™: 95/100 with 2 warning signs

No single metric tells the full story. See the LTS:0GTN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

BioGaia AB Business Description

Other Exchanges BIOG B:SwedenBGLA:Germany
Address Kungsbroplan 3A, Stockholm, SWE, SE-112 27
BioGaia AB is a healthcare company engaged in developing, marketing, and selling probiotic products. The company has three operating segments; Paediatrics segment includes drops, gut health tablets, oral rehydration solution (ORS) and cultures to be used as ingredients in licensee products such as infant formula, as well as royalty revenue for pediatric products, Adult Health segment includes gut health tablets, oral health lozenges and cultures as an ingredient in a licensee's dairy products, and Other segment include royalties in respect of development projects, revenue from packaging solutions in the subsidiary CapAble, etc. Geographically, it operates in three regions: EMEA, the Americas, and APAC (Asia-Pacific, Australia, and New Zealand).
95GF Score

Get the complete analysis for LTS:0GTN

Short Percentage of Float is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr115.51
Price
kr127.39
GF Value